Verma et al., Gene therapy-promises, problems and prospects, 1997, NATURE, vol. 389, pp. 239-242.* |
Song et al., Plasmid DNA encoding transforming growth factor-Beta 1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model, vol. 101, pp. 2615-2621.* |
Fox et al., Biological therapies: A novel approach to the treatment of autoimmune disease, 1995, The American Journal of Medicine, vol. 99, pp. 82-88.* |
Pelletier et al., In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy, 1997, Athritis & Rheumatism, vol. 40, pp. 1012-1019.* |
Crystal, Transfer of genes to humans: Early lessons and obstacles to success, 1995, SCIENCE, vol. 270, pp. 404-410.* |
Deonarain, Ligand-targeted receptor-mediated vectors for gene delivery, 1998, Exp. Opin. Ther. Patents, vol. 8, pp. 53-69.* |
Miller et al., Targeted vectors for gene therapy, 1995, FASEB, vol. 9, pp. 190-199.* |
Chernajovsky et al., Pathogenic lymphoid cells engineered to express TGF Beta 1 ameliorate disease in a collagen-induced arthritis model, 1997, Gene Therapy, vol. 4, pp. 553-559.* |
Van Beuningen et al., Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation, 1998, Osteoarthritis and Cartilage, vol. 6, pp. 306-317.* |
Ikeda et al., adenovirus mediated gene delivery to the joints of guinea pigs, 1998, The Journal of Rheumatology, vol. 25, pp. 1666-1673. |